Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance
KJ Gotink, HJ Broxterman, M Labots, RR De Haas… - Clinical Cancer …, 2011 - AACR
Purpose: Resistance to antiangiogenic tyrosine kinase inhibitors such as sunitinib is an
important clinical problem, but its underlying mechanisms are largely unknown. We …
important clinical problem, but its underlying mechanisms are largely unknown. We …
[PDF][PDF] Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance
KJ Gotink, HJ Broxterman, M Labots… - VU Research …, 2011 - research.vu.nl
Purpose: Resistance to anti-angiogenic tyrosine kinase inhibitors such as sunitinib is an
important clinical problem, but its underlying mechanisms are largely unknown. We …
important clinical problem, but its underlying mechanisms are largely unknown. We …
Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance
KJ Gotink, HJ Broxterman, M Labots… - … : an official journal …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose Resistance to antiangiogenic tyrosine kinase inhibitors such as sunitinib is an
important clinical problem, but its underlying mechanisms are largely unknown. We …
important clinical problem, but its underlying mechanisms are largely unknown. We …
[引用][C] Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
KJ GOTINK, HJ BROXTERMAN… - Clinical cancer …, 2011 - pascal-francis.inist.fr
Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
[HTML][HTML] Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
KJ Gotink, HJ Broxterman, M Labots… - … cancer research: an …, 2011 - ncbi.nlm.nih.gov
Purpose Resistance to antiangiogenic tyrosine kinase inhibitors such as sunitinib is an
important clinical problem, but its underlying mechanisms are largely unknown. We …
important clinical problem, but its underlying mechanisms are largely unknown. We …
Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
KJ Gotink, HJ Broxterman, M Labots… - Clinical Cancer …, 2011 - cir.nii.ac.jp
< jats: title> Abstract</jats: title>< jats: p> Purpose: Resistance to antiangiogenic tyrosine
kinase inhibitors such as sunitinib is an important clinical problem, but its underlying …
kinase inhibitors such as sunitinib is an important clinical problem, but its underlying …
[PDF][PDF] Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
KJ Gotink, HJ Broxterman, M Labots, RR de Haas… - academia.edu
Purpose: Resistance to antiangiogenic tyrosine kinase inhibitors such as sunitinib is an
important clinical problem, but its underlying mechanisms are largely unknown. We …
important clinical problem, but its underlying mechanisms are largely unknown. We …
Lysosomal sequestration of sunitinib: A novel mechanism of drug resistance
KJ Gotink, HJ Broxterman, M Labots… - Clinical Cancer …, 2011 - pure.johnshopkins.edu
Purpose: Resistance to antiangiogenic tyrosine kinase inhibitors such as sunitinib is an
important clinical problem, but its underlying mechanisms are largely unknown. We …
important clinical problem, but its underlying mechanisms are largely unknown. We …
[引用][C] Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance
KJ Gotink, HJ Broxterman… - Clinical …, 2011 - researchinformation.amsterdamumc …
Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance — Amsterdam
UMC research portal Skip to main navigation Skip to search Skip to main content Amsterdam …
UMC research portal Skip to main navigation Skip to search Skip to main content Amsterdam …
[PDF][PDF] Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
KJ Gotink, HJ Broxterman, M Labots, RR de Haas… - 2011 - Citeseer
Purpose: Resistance to antiangiogenic tyrosine kinase inhibitors such as sunitinib is an
important clinical problem, but its underlying mechanisms are largely unknown. We …
important clinical problem, but its underlying mechanisms are largely unknown. We …